Skip to main content
. Author manuscript; available in PMC: 2014 Mar 10.
Published in final edited form as: Contemp Clin Trials. 2012 Nov 29;34(2):232–238. doi: 10.1016/j.cct.2012.11.005

Table 1.

Baseline characteristics by study cohort

AZ0001 N=139 AZ0004 N=191 EPIC N=46 Total N=376

Male 68 (48.9%) 109 (57.1%) 18 (39.1%) 195 (51.9%)

Age (years)
 6–12 18 (12.9%) 130 (68.1%) 44 (95.7%) 192 (51.1%)
 >12–18 59 (42.4%) 61 (31.9%) 2 (4.3%) 122 (32.4%)
 >18 62 (44.6%) 0 (0.0%) 0 (0.0%) 62 (16.5%)
 mean (SD) 20.24 (8.379) 10.76 (3.246) 8.85 (2.087) 14.03 (7.398)

Genotype
 Delta F508 Homozygous 60 (43.2%) 87 (45.5%) 25 (54.3%) 172 (45.7%)
 Delta F508 Heterozygous 42 (30.2%) 60 (31.4%) 14 (30.4%) 116 (30.9%)
 Other 6 (4.3%) 17 (8.9%) 4 (8.7%) 27 (7.2%)

 Not Done 31 (22.3%) 27 (14.1%) 3 (6.5%) 61 (16.2%)

Weight (kg)
 mean (SD) 53.69 (13.135) 37.96 (14.435) 29.93 (8.478) 42.82 (15.935)

Weight (%)a
 mean (SD) 34.08 (27.974) 43.95 (26.806) 41.27 (27.429) 41.07 (27.427)

BMI (kg/m2)
 mean (SD) 20.12 (3.105) 17.87 (2.947) 17.16 (2.123) 18.58 (3.135)

BMI (%)a
 mean (SD) 39.29 (28.207) 49.59 (26.231) 53.43 (25.889) 47.53 (27.074)

FEV 1 % predicted
 mean (SD) 68.23 (20.997) 98.54 (15.907) 97.30 (16.628) 87.10 (23.156)
a

Weight and BMI percentiles calculated for those subjects ≤ 20 years of age using Center for Disease Control standard equations.